Loading clinical trials...

Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT01424384

Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic

This will be a phase I, single centre, randomised, double blind, double-dummy, placebo controlled, parallel group single-dose study in healthy volunteers. The purpose of this study is to assess the ef...

Lead sponsor: GlaxoSmithKline•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDPhase 1

A First Time in Human Study of GSK586529 in Healthy Volunteers

NCT00703547 · Depressive Disorder and Anxiety Disorders

COMPLETEDPhase 1

First Study in Humans With GSK206136

NCT01059578 · Depressive Disorder and Anxiety Disorders

COMPLETEDPhase 1

A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

NCT00513565 · Depressive Disorder and Anxiety Disorders

COMPLETEDPhase 1

Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

NCT00435695 · Healthy Subjects, Depressive Disorder and Anxiety Disorders

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 7, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment54

Start dateSep 2008

Last updatedJul 7, 2017

Condition

Depressive Disorder and Anxiety Disorders

Locations shown

GSK Investigational Site

Oxford

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 7, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

A First Time in Human Study of GSK586529 in Healthy Volunteers

First Study in Humans With GSK206136

A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers

Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males

Trial snapshot

Condition

Locations shown

For caregivers